# GO_molecular_function_0127

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_molecular_function`  
**Author expected answer:** **C** — sodium channel inhibitor activity

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MMKTVIVLIVFSLVMIVVKSDNGYLLDKYTGCKIWCVINNDSCNSHCIGSGGYYGYCYFWKLACYCQGAPRSELWHYETNRCRA

[Multiple Choices]
A. protein folding chaperone
B. calcium channel activity
C. sodium channel inhibitor activity
D. histone reader activity
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt entry assigns sodium channel inhibitor activity by IEA:InterPro, including in the historical record. This supports the key as a computational GO annotation, not as an experimentally demonstrated activity in the supplied evidence; the cited experimental function is antimicrobial activity.

Citations as saved: [C6](#evidence-c6), [H4](#evidence-h4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The cysteine-rich peptide sequence is compatible with a scorpion venom peptide and makes chaperone, calcium-channel pore, and histone-reader functions poor fits. That general clue does not establish sodium-channel inhibition specifically.


**Missing item-specific fact**

> A protein-specific sodium-channel inhibitor annotation or functional measurement is needed to distinguish C from other possible activities of a venom peptide.


**Reason**

> The key is supported by an external computational annotation, but the input sequence and choices do not provide a decisive biological argument for this precise function.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Only C is a plausible choice among those listed for a venom peptide, though the sequence alone does not establish that specific activity.


### Important caveats

- The GO sodium-channel annotation is IEA:InterPro, not experimental evidence.
- The matched entry cites experimental antimicrobial activity; the excerpts do not establish sodium-channel inhibition experimentally.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The cysteine-rich peptide sequence is compatible with a scorpion venom peptide and makes chaperone, calcium-channel pore, and histone-reader functions poor fits. That general clue does not establish sodium-channel inhibition specifically.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "A protein-specific sodium-channel inhibitor annotation or functional measurement is needed to distinguish C from other possible activities of a venom peptide.",
    "reason": "The key is supported by an external computational annotation, but the input sequence and choices do not provide a decisive biological argument for this precise function."
  },
  "case_id": "GO_molecular_function_0127",
  "expected_answer_check": {
    "evidence_ids": [
      "C6",
      "H4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt entry assigns sodium channel inhibitor activity by IEA:InterPro, including in the historical record. This supports the key as a computational GO annotation, not as an experimentally demonstrated activity in the supplied evidence; the cited experimental function is antimicrobial activity."
  },
  "important_caveats": [
    "The GO sodium-channel annotation is IEA:InterPro, not experimental evidence.",
    "The matched entry cites experimental antimicrobial activity; the excerpts do not establish sodium-channel inhibition experimentally."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Only C is a plausible choice among those listed for a venom peptide, though the sequence alone does not establish that specific activity."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0127",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt entry assigns sodium channel inhibitor activity by IEA:InterPro, including in the historical record. This supports the key as a computational GO annotation, not as an experimentally demonstrated activity in the supplied evidence; the cited experimental function is antimicrobial activity.",
    "evidence_ids": ["C6", "H4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The cysteine-rich peptide sequence is compatible with a scorpion venom peptide and makes chaperone, calcium-channel pore, and histone-reader functions poor fits. That general clue does not establish sodium-channel inhibition specifically.",
    "missing_item_specific_fact": "A protein-specific sodium-channel inhibitor annotation or functional measurement is needed to distinguish C from other possible activities of a venom peptide.",
    "reason": "The key is supported by an external computational annotation, but the input sequence and choices do not provide a decisive biological argument for this precise function."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Only C is a plausible choice among those listed for a venom peptide, though the sequence alone does not establish that specific activity."
  },
  "important_caveats": [
    "The GO sodium-channel annotation is IEA:InterPro, not experimental evidence.",
    "The matched entry cites experimental antimicrobial activity; the excerpts do not establish sodium-channel inhibition experimentally."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt F6K6F3 (sequence matched) carries GO:0019871 'sodium channel inhibitor activity' (evidence C6/H4), annotated via IEA:InterPro. The peptide is named MeuNaTxbeta-2 (NaTx = sodium channel toxin family), from scorpion venom. However, the primary experimental evidence (PubMed:29770866, ECO:0000269) describes antimicrobial activity, not direct sodium channel inhibition. The sodium channel inhibitor annotation is a computational family-membership inference (IEA:InterPro), not experimentally demonstrated channel inhibition. The key is supported by database annotation but at a low evidence level.

Citations as saved: [C6](#evidence-c6), [H4](#evidence-h4), [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 84-residue sequence contains an N-terminal hydrophobic signal peptide (MMKTVIVLIVFSLVMIVVKS) and a mature secreted region with 12 cysteines forming a small disulfide-rich peptide. This architecture is fundamentally incompatible with: (A) protein folding chaperone (requires large multi-domain proteins like HSPs, 20–100+ kDa), (B) calcium channel activity (requires a transmembrane pore-forming protein with multiple helical segments), and (D) histone reader activity (requires nuclear chromatin-binding domains such as bromodomain/PHD finger). Among the four choices, only C (sodium channel inhibitor activity) is consistent with a small, secreted, disulfide-stabilized peptide that acts as a toxin modulating ion channels—a well-known class of venom peptides.


**Missing item-specific fact**

> None strictly required to select C among the given four options; elimination of A, B, D by basic structural biology leaves C as the only plausible choice for a small secreted cysteine-rich peptide.


**Reason**

> The sequence features (small size, signal peptide, high cysteine content, no transmembrane segments, no catalytic or binding domains for chaperone/channel/histone-reader functions) allow a model with general biological knowledge to eliminate three options and select C without needing to identify the exact UniProt entry or recall a specific database annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the four provided choices, A, B, and D are structurally and functionally incompatible with a small secreted disulfide-rich peptide. C is the only option consistent with the observed sequence architecture. Although the UniProt entry also annotates GO:0090729 'toxin activity' and experimental evidence describes antimicrobial activity, neither is offered as a choice, so no ambiguity exists within the given options.


### Important caveats

- The GO:0019871 annotation is IEA:InterPro (computational inference from InterPro domain match), not experimental demonstration of sodium channel inhibition.
- The primary experimental evidence (PubMed:29770866) characterizes this peptide as an antimicrobial peptide, not as a sodium channel inhibitor per se.
- The peptide name 'MeuNaTxbeta-2' reflects family membership in the NaTx toxin superfamily, which is the basis for the InterPro-based GO assignment.
- All reviewer evidence is post-hoc; the evaluated model only sees the raw sequence and four options.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 84-residue sequence contains an N-terminal hydrophobic signal peptide (MMKTVIVLIVFSLVMIVVKS) and a mature secreted region with 12 cysteines forming a small disulfide-rich peptide. This architecture is fundamentally incompatible with: (A) protein folding chaperone (requires large multi-domain proteins like HSPs, 20–100+ kDa), (B) calcium channel activity (requires a transmembrane pore-forming protein with multiple helical segments), and (D) histone reader activity (requires nuclear chromatin-binding domains such as bromodomain/PHD finger). Among the four choices, only C (sodium channel inhibitor activity) is consistent with a small, secreted, disulfide-stabilized peptide that acts as a toxin modulating ion channels—a well-known class of venom peptides.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required to select C among the given four options; elimination of A, B, D by basic structural biology leaves C as the only plausible choice for a small secreted cysteine-rich peptide.",
    "reason": "The sequence features (small size, signal peptide, high cysteine content, no transmembrane segments, no catalytic or binding domains for chaperone/channel/histone-reader functions) allow a model with general biological knowledge to eliminate three options and select C without needing to identify the exact UniProt entry or recall a specific database annotation."
  },
  "case_id": "GO_molecular_function_0127",
  "expected_answer_check": {
    "evidence_ids": [
      "C6",
      "H4",
      "C5",
      "H3",
      "C4"
    ],
    "judgment": "supported",
    "reason": "UniProt F6K6F3 (sequence matched) carries GO:0019871 'sodium channel inhibitor activity' (evidence C6/H4), annotated via IEA:InterPro. The peptide is named MeuNaTxbeta-2 (NaTx = sodium channel toxin family), from scorpion venom. However, the primary experimental evidence (PubMed:29770866, ECO:0000269) describes antimicrobial activity, not direct sodium channel inhibition. The sodium channel inhibitor annotation is a computational family-membership inference (IEA:InterPro), not experimentally demonstrated channel inhibition. The key is supported by database annotation but at a low evidence level."
  },
  "important_caveats": [
    "The GO:0019871 annotation is IEA:InterPro (computational inference from InterPro domain match), not experimental demonstration of sodium channel inhibition.",
    "The primary experimental evidence (PubMed:29770866) characterizes this peptide as an antimicrobial peptide, not as a sodium channel inhibitor per se.",
    "The peptide name 'MeuNaTxbeta-2' reflects family membership in the NaTx toxin superfamily, which is the basis for the InterPro-based GO assignment.",
    "All reviewer evidence is post-hoc; the evaluated model only sees the raw sequence and four options."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the four provided choices, A, B, and D are structurally and functionally incompatible with a small secreted disulfide-rich peptide. C is the only option consistent with the observed sequence architecture. Although the UniProt entry also annotates GO:0090729 'toxin activity' and experimental evidence describes antimicrobial activity, neither is offered as a choice, so no ambiguity exists within the given options."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0127",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt F6K6F3 (sequence matched) carries GO:0019871 'sodium channel inhibitor activity' (evidence C6/H4), annotated via IEA:InterPro. The peptide is named MeuNaTxbeta-2 (NaTx = sodium channel toxin family), from scorpion venom. However, the primary experimental evidence (PubMed:29770866, ECO:0000269) describes antimicrobial activity, not direct sodium channel inhibition. The sodium channel inhibitor annotation is a computational family-membership inference (IEA:InterPro), not experimentally demonstrated channel inhibition. The key is supported by database annotation but at a low evidence level.",
    "evidence_ids": ["C6", "H4", "C5", "H3", "C4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 84-residue sequence contains an N-terminal hydrophobic signal peptide (MMKTVIVLIVFSLVMIVVKS) and a mature secreted region with 12 cysteines forming a small disulfide-rich peptide. This architecture is fundamentally incompatible with: (A) protein folding chaperone (requires large multi-domain proteins like HSPs, 20–100+ kDa), (B) calcium channel activity (requires a transmembrane pore-forming protein with multiple helical segments), and (D) histone reader activity (requires nuclear chromatin-binding domains such as bromodomain/PHD finger). Among the four choices, only C (sodium channel inhibitor activity) is consistent with a small, secreted, disulfide-stabilized peptide that acts as a toxin modulating ion channels—a well-known class of venom peptides.",
    "missing_item_specific_fact": "None strictly required to select C among the given four options; elimination of A, B, D by basic structural biology leaves C as the only plausible choice for a small secreted cysteine-rich peptide.",
    "reason": "The sequence features (small size, signal peptide, high cysteine content, no transmembrane segments, no catalytic or binding domains for chaperone/channel/histone-reader functions) allow a model with general biological knowledge to eliminate three options and select C without needing to identify the exact UniProt entry or recall a specific database annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the four provided choices, A, B, and D are structurally and functionally incompatible with a small secreted disulfide-rich peptide. C is the only option consistent with the observed sequence architecture. Although the UniProt entry also annotates GO:0090729 'toxin activity' and experimental evidence describes antimicrobial activity, neither is offered as a choice, so no ambiguity exists within the given options."
  },
  "important_caveats": [
    "The GO:0019871 annotation is IEA:InterPro (computational inference from InterPro domain match), not experimental demonstration of sodium channel inhibition.",
    "The primary experimental evidence (PubMed:29770866) characterizes this peptide as an antimicrobial peptide, not as a sodium channel inhibitor per se.",
    "The peptide name 'MeuNaTxbeta-2' reflects family membership in the NaTx toxin superfamily, which is the basis for the InterPro-based GO assignment.",
    "All reviewer evidence is post-hoc; the evaluated model only sees the raw sequence and four options."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `F6K6F3` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 45. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K6F3.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:17.591838+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000312","id":"ADT89767.1","source":"EMBL"}],"value":"Antibacterial peptide MeuNaTx-15"}}],"flag":"Precursor","recommendedName":{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"29770866","source":"PubMed"}],"value":"Antimicrobial peptide MeuNaTxbeta-2"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"29770866","source":"PubMed"}],"value":"MTbeta-2"}]}}
```

Source SHA-256: `2f8ddf5a02bb62a6e8fdafffdf12262a0a9c5e67c732840115366acaca672a71`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K6F3.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:17.591838+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"29770866","source":"PubMed"}],"value":"Antimicrobial peptide with activity against both Gram-positive and -negative bacteria"}]}
```

Source SHA-256: `2f8ddf5a02bb62a6e8fdafffdf12262a0a9c5e67c732840115366acaca672a71`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K6F3.json)  
**Locator:** `/uniProtKBCrossReferences/4`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:17.591838+00:00.  

```json
{"database":"GO","id":"GO:0019871","properties":[{"key":"GoTerm","value":"F:sodium channel inhibitor activity"},{"key":"GoEvidenceType","value":"IEA:InterPro"}]}
```

Source SHA-256: `2f8ddf5a02bb62a6e8fdafffdf12262a0a9c5e67c732840115366acaca672a71`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/F6K6F3?format=txt&versions=45)  
**Locator:** `lines 30-31`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 45 / 1.  
**Retrieved:** 2026-11-02T04:28:19.832132+00:00.  

```text
CC   -!- FUNCTION: Antimicrobial peptide with activity against both Gram-
CC       positive and -negative bacteria. {ECO:0000269|PubMed:29770866}.
```

Source SHA-256: `4f110a7548ccfcd43132cf259deffb971397d09e10bfe54c7983dbaabaeaa24c`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/F6K6F3?format=txt&versions=45)  
**Locator:** `lines 47-47`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 45 / 1.  
**Retrieved:** 2026-11-02T04:28:19.832132+00:00.  

```text
DR   GO; GO:0019871; F:sodium channel inhibitor activity; IEA:InterPro.
```

Source SHA-256: `4f110a7548ccfcd43132cf259deffb971397d09e10bfe54c7983dbaabaeaa24c`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json), zero-based source row 127. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
